GNMX
Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF
1W: -0.7%
1M: +5.9%
YTD: +4.2%
$37.73
+0.38 (+1.03%)
Weekly Expected Move ±3.8%
$35
$36
$38
$39
$41
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
Portfolio Health Summary
IS Overall Score
48.0
★★★★★
Altman Z-Score
7.48
Safe
Weight Coverage
96%
of portfolio analyzed
Holdings Matched
56
with fundamental data
InsiderStreet Scorecard
★★★★★
48.0
Top Holdings: Score Breakdown
Risk & Quality Signals
Altman Z-Score
7.48
Safe Zone (>2.99)
Piotroski F-Score
4.8 / 9
Moderate
Beneish M-Score
-31.94
Unlikely Manipulator
Credit Score
—
Earnings Quality
58.7 / 100
Portfolio Valuation
P/E
43.95x
P/B
5.91x
P/S
7.49x
EV/EBITDA
30.93x
EV/Revenue
8.03x
P/FCF
42.89x
P/OCF
36.03x
PEG
7.09x
Earnings Yield
2.28%
FCF Yield
2.33%
OCF Yield
2.78%
Median P/E
-6.81x
Growth & Shareholder Returns
Year-over-Year Growth
Revenue
+14.5%
Net Income
+6.1%
EPS
+10.9%
FCF
+16.7%
EBITDA
+19.1%
Op. Income
—
Compound Growth Rates
Rev CAGR 3Y
+44.2%
Rev CAGR 5Y
+13.1%
EPS CAGR 3Y
+6.2%
EPS CAGR 5Y
+2.0%
FCF CAGR 3Y
+16.5%
FCF CAGR 5Y
+4.8%
EBITDA CAGR 3Y
+1.2%
EBITDA CAGR 5Y
+5.4%
Payout Ratio
4.13%
Buyback Yield
8.86%
Dividend Yield
0.15%
Total Shareholder Return
4.52%
Earnings Stability
All Ratios & Metrics
Valuation (12)
| Metric | Value |
|---|---|
| Portfolio P/E | 43.95 |
| Portfolio P/B | 5.91 |
| Portfolio P/S | 7.49 |
| EV/EBITDA | 30.93 |
| EV/Revenue | 8.03 |
| P/FCF | 42.89 |
| P/OCF | 36.03 |
| PEG | 7.09 |
| Earnings Yield | 2.28% |
| FCF Yield | 2.33% |
| OCF Yield | 2.78% |
| Median P/E | -6.81 |
Profitability & Returns (9)
| Metric | Value |
|---|---|
| Gross Margin | 52.41% |
| Operating Margin | 12.31% |
| Net Margin | 9.73% |
| FCF Margin | 13.43% |
| ROE | 7.44% |
| ROA | 4.05% |
| ROIC | 6.92% |
| ROCE | — |
| Asset Turnover | — |
Leverage & Solvency (6)
| Metric | Value |
|---|---|
| Debt/Equity | 0.61 |
| Debt/Assets | 0.31 |
| Net Debt/EBITDA | 1.63 |
| Interest Coverage | 5.11 |
| Current Ratio | 2.14 |
| Quick Ratio | 1.79 |
Efficiency (4)
| Metric | Value |
|---|---|
| Asset Turnover | — |
| Inventory Turnover | — |
| Receivables Turnover | — |
| Payables Turnover | — |
Growth — YoY (6)
| Metric | Value |
|---|---|
| Revenue Growth | 14.52% |
| Net Income Growth | 6.11% |
| EPS Growth | 10.94% |
| FCF Growth | 16.73% |
| EBITDA Growth | 19.08% |
| Op. Income Growth | — |
Growth — CAGR (16)
| Metric | Value |
|---|---|
| Revenue CAGR 3Y | 44.24% |
| Revenue CAGR 5Y | 13.06% |
| Revenue CAGR 10Y | — |
| EPS CAGR 3Y | 6.20% |
| EPS CAGR 5Y | 2.03% |
| EPS CAGR 10Y | — |
| FCF CAGR 3Y | 16.53% |
| FCF CAGR 5Y | 4.80% |
| FCF CAGR 10Y | — |
| EBITDA CAGR 3Y | 1.21% |
| EBITDA CAGR 5Y | 5.43% |
| EBITDA CAGR 10Y | — |
| Net Income CAGR 3Y | 4.65% |
| Net Income CAGR 5Y | 1.31% |
| Op. Income CAGR 3Y | — |
| Op. Income CAGR 5Y | — |
Quality Scores (13)
| Metric | Value |
|---|---|
| IS Overall | 48.0 |
| IS Profitability | 39.0 |
| IS Balance Sheet | 51.1 |
| IS Earnings Quality | 58.7 |
| IS Growth | 52.2 |
| IS Value | 39.4 |
| IS Momentum | 61.9 |
| IS Safety | 77.6 |
| IS Quality | 57.4 |
| Altman Z-Score | 7.48 |
| Piotroski F-Score | 4.81 |
| Beneish M-Score | -31.94 |
| Credit Score | — |
Dividends & Payout (4)
| Metric | Value |
|---|---|
| Dividend Yield | 0.15% |
| Payout Ratio | 4.13% |
| Buyback Yield | 8.86% |
| Total Shareholder Return | 4.52% |
Growth Stability (4)
| Metric | Value |
|---|---|
| Revenue Stability | 0.706 |
| Earnings Stability | 0.322 |
| Earnings Persistence | 0.710 |
| Margin Stability | 0.663 |
Medians (3)
| Metric | Value |
|---|---|
| Median P/E | -6.81 |
| Median P/B | 3.61 |
| Median Dividend Yield | — |
Coverage Meta (3)
| Metric | Value |
|---|---|
| Weight Coverage % | 95.98% |
| Holdings Matched | 56 |
| Total Holdings | 57 |